Fierce Pharma Feature: Small molecule biomarkers in precision medicine

This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.

Frontiers Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer

Frontiers MicroRNA as an Important Target for Anticancer Drug Development

Trending 2017: Precision Medicine

Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes

Fierce Pharma Feature: Small molecule biomarkers in precision medicine

AI Drug Discovery: Key Trends and Developments in Pharma Industry

Sensing Biomarkers with Plasmonics

Automated next-generation profiling of genomic alterations in human cancers

Skin-Interfaced Wearable Sweat Sensors for Precision Medicine

Biomedicines, Free Full-Text

Fresh from the biotech pipeline: fewer approvals, but biologics gain share

Frontiers Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine

2018's Fiercest Women in Life Sciences

The expanding role for small molecules in immuno-oncology

EGFR Leaders in Pharmaceutical Business Intelligence (LPBI) Group